Bipolar Disorder
- We are currently enrolling clinical trials for children and adolescents with Bipolar Disorder:
- Males and females age 10 to 17
- Previous diagnosis of bipolar disorder is not required
- Compensation: Up to $350
- Learn more about bipolar disorder.
- Click here to learn more about the Pfizer bipolar study on the ClinicalTrials.gov website.
Depression
- Do you suspect that your child or adolescent may be depressed? We are currently offering a clinical trial for children and adolescents with depression
- Males and females age 7 to 17
- Previous diagnosis of depression is not required
- 3-5 brief therapy sessions included
- Compensation: Up to $600
- Learn more about depression.
- Learn more about the Kites study.
- Click on the links below to learn more about each age group in the Kites study on the ClinicalTrials.gov website:
Pediatric Migraine
Does your child or teen suffer from moderate or severe migraine?
Now enrolling: a clinical study to evaluate the safety and efficacy of a dissolving tablet called rimegepant in children and teens 6 to 17 years old with moderate or severe migraine. Rimegepant is approved by the US Food and Drug Administration (FDA) for the acute treatment of migraine in adults.
To be eligible for this study, participants must:
- Be 6 to 17 years old
- Have a history of migraine for 6 months or longer
- Have a history of 1 to 8 moderate or severe migraine attacks (lasting more than 3 hours without treatment) per month during the past 2 months.
- Be able to understand the assent form and have parent(s)/caregiver(s) who can give informed consent.
his is not a complete list of study requirements. The study doctor will review all requirements with you and your child or teen.
Tourette Disorder
- We are currently enrolling children in the Tourette Disorder study:
- Males and females age 6 to 17
- Meets DSM5 diagnosis for Tourette's Disorder
- Participation could last up to 10 months with about 17 office visits.
- Compensation: Up to $775
- Learn more about the Tourette’s study.
- Click here to learn more about the Tourette’s study on the ClinicalTrials.gov website.
